How is a respiratory infection changing over time?
Assessing respiratory virus seroprevalence in blood donors
Challenge
Reported cases of respiratory infections represent a subset of total infections because some infected people had mild or no symptoms or did not seek medical care or get tested. Furthermore, the availability of viral testing was limited.
The Centers for Disease Control and Prevention’s (CDC’s) conducted a multistate assessment of a respiratory virus seroprevalence in blood donor samples from 60+ metropolitan regions in the U.S. for the presence of respiratory virus antibodies.
Solution
Westat provided study coordination, data collection and management, and analytical services.
Using U.S. census data, we weighted the results to extrapolate seroprevalence data from blood donor samples to the general community in the geographic regions in which the blood donors lived.
Results
This seroprevalence study allows CDC to:
- Assess increasing penetrance of the respiratory infection into distinct U.S. communities
- Determine overall seroprevalence at various points in time
-
Expert Interview
Real-World Insights: Nirsevimab’s Protection Against RSV in InfantsSeptember 2025
Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…
-
Perspective
Westat @ JSM 2025: Enriching Society with StatisticsJuly 2025
Westat staff will be participating in the 2025 Joint Statistical Meetings (JSM), the largest annual gathering of statisticians and data scientists in North America. Held…
-
Expert Interview
2026 ASA President Mulrow: Communities in Action Advancing SocietyJuly 2025
Jeri Mulrow, MS, Vice President and Sector Lead for Data Solutions at Westat, will serve as the 121st President of the American Statistical Association (ASA),…